New treatment approach uses killer cells to treat deadly brain tumors
(Purdue University) A Purdue University cancer innovator and his team have developed a promising new approach to treating glioblastomas using a type of immune cell called the natural killer (NK) cell. The team genetically modifies the NK cells to more specifically target and kill cancer cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2020 Category: International Medicine & Public Health Source Type: news

Outpatient Brain Tumor Surgery Feasible, Safe Outpatient Brain Tumor Surgery Feasible, Safe
In carefully selected patients who have few comorbidities, outpatient treatment may be appropriate and preferable for brain tumor resection during the COVID-19 pandemic.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - July 8, 2020 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

New treatment strategy may benefit patients with brain cancer
(Massachusetts General Hospital) A team led by investigators at Massachusetts General Hospital has uncovered a potentially promising strategy to treat gliomas with mutations in the IDH genes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2020 Category: Cancer & Oncology Source Type: news

St. Jude creates resource for pediatric brain tumor research
(St. Jude Children's Research Hospital) Researchers worldwide can access orthotopic patient-derived xenograft models to speed discovery and test novel therapies for childhood brain tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 23, 2020 Category: International Medicine & Public Health Source Type: news

New radioisotope therapy treats pediatric neuroblastoma
Japanese researchers have discovered a new radioisotope therapy for children...Read more on AuntMinnie.comRelated Reading: Researchers link brain tumor treatment to GBCA deposition AJR paper describes errors in pediatric radiography Whole-body MRI has mixed results in pediatric cancer patients Dell donates cloud cluster for pediatric cancer trial Protocols protect pediatric caregivers from I-131 exposure (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 23, 2020 Category: Radiology Source Type: news

Imaging Biometrics touts IB-Neuro recognition
Advanced visualization software firm Imaging Biometrics is touting the recognition...Read more on AuntMinnie.comRelated Reading: Imaging Biometrics secures $2.57M grant AI Metrics joins forces with Imaging Biometrics Imaging Biometrics nets NIH grant Imaging Biometrics points to brain tumor study Imaging Biometrics teams with CorTechs Labs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2020 Category: Radiology Source Type: news

Focused ultrasound shows promise against deadliest brain tumor
(University of Virginia Health System) Focused sound waves create tiny bubbles inside cancer cells, causing them to die. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2020 Category: International Medicine & Public Health Source Type: news

Diagnosing brain tumors with a blood test
(University Health Network) A simple but highly sensitive blood test has been found to accurately diagnose and classify different types of brain tumours, resulting in more accurate diagnosis, less invasive methods and better treatment planning in the future for the patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2020 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Announces Winners of 2020 Women in STEM2D Scholars Award
(New Brunswick, N.J. – June 18) – Johnson & Johnson today announced the six winners of the third annual Johnson & Johnson Women in STEM2D (WiSTEM2D) Scholars Award. Each recipient, representing each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design, will receive a grant of $150,000 and three years of mentorship. Launched in June 2017, the Johnson & Johnson WiSTEM2D Scholars Award seeks to fuel development of future female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their careers. The goal is to su...
Source: Johnson and Johnson - June 18, 2020 Category: Pharmaceuticals Source Type: news

CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
HOUSTON, June 11, 2020 -- (Healthcare Sales & Marketing Network) -- CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and me... Biopharmaceuticals, Oncology, Neurology, FDA CNS Pharmaceuticals, Berubicin, glioma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2020 Category: Pharmaceuticals Source Type: news

Artificial intelligence enhances brain tumour diagnosis
(Kyoto University) A new machine learning approach classifies a common type of brain tumour into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access. Scientists in India and Japan, including from Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), developed the method to help clinicians choose the most effective treatment strategy for individual patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2020 Category: International Medicine & Public Health Source Type: news

New method to identify genes that can drive development of brain tumors
(Uppsala University) Researchers at Uppsala University have developed a method for identifying functional mutations and their effect on genes relevant to the development of glioblastoma. The results show that a specific, evolutionarily conserved, mutation in the vicinity of SEMA3C disrupts the binding of certain proteins whose task is to bind genes and regulate their activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2020 Category: Cancer & Oncology Source Type: news

Imaging Biometrics secures $2.57M grant
Advanced visualization software firm Imaging Biometrics has received a five-year,...Read more on AuntMinnie.comRelated Reading: AI Metrics joins forces with Imaging Biometrics Imaging Biometrics nets NIH grant Imaging Biometrics points to brain tumor study Imaging Biometrics teams with CorTechs Labs Imaging Biometrics debuts IB Server software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 9, 2020 Category: Radiology Source Type: news

Scientists discover that nicotine promotes spread of lung cancer to the brain
(Wake Forest Baptist Medical Center) Among people who have the most common type of lung cancer, up to 40% develop metastatic brain tumors, with an average survival time of less than six months. But why non-small-cell lung cancer so often spreads to the brain has been poorly understood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

Continued nicotine use promotes brain tumors in lung cancer patients, study suggests
(Rockefeller University Press) Researchers have discovered that nicotine promotes the spread of lung cancer cells into the brain, where they can form deadly metastatic tumors. The study, which will be published June 4 in the Journal of Experimental Medicine, suggests that nicotine replacement therapies may not be suitable strategies for lung cancer patients attempting to quit smoking. In addition, the researchers show that the naturally occurring drug parthenolide blocks nicotine-induced brain metastasis in mice, suggesting a potential therapeutic option in humans. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 4, 2020 Category: International Medicine & Public Health Source Type: news

Ludwig Lausanne study charts the immune landscape of multiple brain cancers
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has profiled, in a sweeping comparative analysis, the distinct immune landscapes of tumors that arise in the brain, or gliomas, and those that metastasize to the organ from the lungs, breast and skin. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 28, 2020 Category: Cancer & Oncology Source Type: news

Mapping immune cells in brain tumors
(University of Zurich) It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is necessary. Researchers from the University of Zurich and the UniversityHospital Zurich have now been able to describe, with unparalleled precision, the composition of the immune cells of various types of brain tumors. This will provide an important foundation for future immunotherapy approaches. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 28, 2020 Category: Cancer & Oncology Source Type: news

The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Bacteria were first detected in human tumors more than 100 years ago, but the characterization of the tumor microbiome has remained challenging because of its low biomass. We undertook a comprehensive analysis of the tumor microbiome, studying 1526 tumors and their adjacent normal tissues across seven cancer types, including breast, lung, ovary, pancreas, melanoma, bone, and brain tumors. We found that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome. The intratumor bacteria are mostly intracellular and are present in both cancer and immune cells. W...
Source: ScienceNOW - May 28, 2020 Category: Science Authors: Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., Meltser, A., Douglas, G. M., Kamer, I., Gopalakrishnan, V., Dadosh, T., Levin-Zaidman, S., Avnet, S., Atlan, T., Cooper, Z. A Tags: Medicine, Diseases, Microbiology r-articles Source Type: news

Scientists identify promising immunotherapy combination for pediatric brain cancer
(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys have discovered that combining immunotherapy with a drug called tumor necrosis factor (TNF) eradicated a deadly type of pediatric brain tumor in mice. The discovery, published in Nature Neuroscience, is expected to lead to a clinical trial to test the benefits of the treatment in patients. The findings also hold implications for other cancers that do not respond to immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 18, 2020 Category: Cancer & Oncology Source Type: news

Welltok adds four new digital programs, Atrium Health adopts Butterfly's handheld ultrasound and more digital health deals
Also: Intel, UPenn and others employ AI for brain tumor identification; DrChrono integrates EHRsynergy's documentation tool. (Source: mobihealthnews)
Source: mobihealthnews - May 14, 2020 Category: Information Technology Source Type: news

Geography of childhood cancer in Switzerland studied
(University of Bern) A research group under the direction of the Institute of Social and Preventive Medicine of the University Bern has investigated the spatial distribution of childhood cancer risks in Switzerland for the period 1985-2015. The group found evidence of increased risks in certain areas, particularly for brain tumors. The researchers demand that the search for the causes of brain tumors in children be intensified. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2020 Category: Cancer & Oncology Source Type: news

Men and women found to have different genetic risk factors for developing brain cancer
(Natural News) Glioma, the most common type of primary brain tumor in the United States, is a malignant disease that affects mostly non-Hispanic whites. It occurs either in the brain or the spinal cord, originating in glial cells that insulate neurons and serve as their support. Depending on their rate of growth and location, gliomas can... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2020 Category: Consumer Health News Source Type: news

Focused ultrasound opening brain to previously impossible treatments
(University of Virginia Health System) Focused ultrasound, the researchers hope, could revolutionize treatment for conditions from Alzheimer's to epilepsy to brain tumors -- and even help repair the devastating damage caused by stroke. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 6, 2020 Category: International Medicine & Public Health Source Type: news

Brain tumors respond well to combo of radiation, schizophrenia drug
Researchers at theUCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.The findings,published May 1 in Proceedings of the National Academy of Sciences, show that a combination of radiation and the drug trifluoperazine not only targets glioblastoma cells but also helps overcome the resistance to treatment so common to this aggressive form of cancer. The results could prove promising for patients wit...
Source: UCLA Newsroom: Health Sciences - May 2, 2020 Category: Universities & Medical Training Source Type: news

New targets for childhood brain tumors identified
(Washington University School of Medicine) People with the genetic condition neurofibromatosis type 1 (NF1) are prone to developing tumors on nervous system tissue. A new study from Washington University School of Medicine in St. Louis has found that the development and growth of such tumors are driven by nearby noncancerous neurons and immune cells. The findings point to potential new therapeutic targets for people with NF1. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Schizophrenia drug combined with radiation shows promise in treating deadly brain tumors
(University of California - Los Angeles Health Sciences) UCLA researchers found adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

A promising new treatment for recurrent pediatric brain cancer
(Baylor College of Medicine) Researchers developed a novel approach that delivers appropriately-targeted chimeric antigen receptor (CAR) T cell therapy directly into the cerebrospinal fluid that surrounds recurrent pediatric brain tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

Could AI Help Doctors Map Out Treatments for Brain Cancers?
FRIDAY, April 24, 2020 -- Artificial intelligence may reduce the need for glioma brain cancer patients to have biopsies to determine the best treatment for their tumors, researchers report. Currently, it's common to remove glioma samples from... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 24, 2020 Category: General Medicine Source Type: news

AI-Assisted MRI Could Eliminate Pre-Treatment Surgery for Brain Tumor
An artificial intelligence algorithm uses 3D MRI images to identify a specific genetic mutation that prompts tumor development. (Source: Diagnostic Imaging)
Source: Diagnostic Imaging - April 23, 2020 Category: Radiology Authors: Whitney J. Palmer Tags: Brain MRI Brain Tumors Source Type: news

Drug prevents cognitive impairment in mice after radiation treatment for brain tumors
FINDINGSA study by researchers at theUCLA Jonsson Comprehensive Cancer Center has identified a possible new drug that could help prevent cognitive decline in people who undergo radiation therapy for brain tumors. The researchers found when the drug was given to mice 24 hours after the animals were exposed to a dose of radiation, it completely prevented cognitive decline from occurring, and that it did not reduce the efficacy of the radiation treatment.This experiment represents one of a very few instances in which a drug reduced cognitive decline in animals after radiation treatment.The drug, NSPP, wasidentified in 2019 by...
Source: UCLA Newsroom: Health Sciences - April 15, 2020 Category: Universities & Medical Training Source Type: news

Study reveals how 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy
(Dana-Farber Cancer Institute) An analysis of more than 10,000 gliomas and clinical outcomes reported in Nature by scientists in Boston and Paris found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2020 Category: International Medicine & Public Health Source Type: news

Drug prevents cognitive impairment in mice after radiation treatment for brain tumors
(University of California - Los Angeles Health Sciences) UCLA researchers identify a new drug that may help prevent cognitive decline in people who undergo radiation therapy for brain tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2020 Category: International Medicine & Public Health Source Type: news

Mouse study shows how advancing glioma cells scramble brain function, blood flow
(The Zuckerman Institute at Columbia University) The first sign of trouble for a patient with a growing brain tumor is often a seizure. Such seizures have long been considered a side effect of the tumor. But now a joint team of Columbia engineers and cancer researchers studying brain tumors has found evidence that the seizures caused by an enlarging tumor could spur its deadly progression. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 14, 2020 Category: Biology Source Type: news

New findings shed light on selective therapeutics for IDH1-mutated glioma
(Chinese Academy of Sciences Headquarters) Findings of a new study led by Prof. XU Guowang from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences and Prof. YANG Chunzhang from the National Cancer Institute shed light on the selective therapeutics for IDH1-mutated glioma by targeting glutathione synthesis pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2020 Category: Cancer & Oncology Source Type: news

Virginia Tech scientists reveal brain tumors impact normally helpful cells
(Virginia Tech) Unprovoked recurrent seizures are a serious problem affecting most patients who suffer from glioma, a primary brain tumor composed of malignant glial cells. Fralin Biomedical Research Institute researchers tested the hypothesis that glioma-induces processes that renders a type of brain cells dysfunctional, perpetuating the imbalance between excitation and inhibition in tumor-associated epilepsy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2020 Category: International Medicine & Public Health Source Type: news

Brain tumors in children: Hereditary genetic defect destabilizes protein regulation
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) The causes of 40 percent of all cases of certain medulloblastoma - dangerous brain tumors affecting children - are hereditary. These are the findings of a recent genetic analysis carried out by scientists from the Hopp Children's Cancer Center (KiTZ), the European Molecular Biology Laboratory (EMBL) and numerous colleagues around the world, which have just been published in the scientific journal Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2020 Category: Cancer & Oncology Source Type: news

Inherited mutation can predispose children to a type of brain tumor
(St. Jude Children's Research Hospital) Collaboration co-led by researchers at St. Jude Children's Research Hospital discovers a novel predisposition gene in pediatric medulloblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2020 Category: Cancer & Oncology Source Type: news

Understanding brain tumors in children
(European Molecular Biology Laboratory) The causes of 40% of all cases of certain medulloblastomas -- dangerous brain tumors affecting children -- are hereditary. These are the findings of a recent genetic analysis carried out by scientists from the European Molecular Biology Laboratory (EMBL) and numerous colleagues around the world. A genetic defect that occurs in 15% of these children plays a key role by destabilizing the production of proteins. The researchers suspect that protein metabolism defects could be a previously underestimated cause of other types of cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2020 Category: Cancer & Oncology Source Type: news

Babies with brain tumors could benefit from targeted treatment
(Institute of Cancer Research) Brain cancer in infants is biologically distinct from other childhood brain tumors and could be successfully treated with targeted drugs, a new study has shown. In the largest and most comprehensive study of infant gliomas to date, scientists found that these tumors are molecularly different from those in older children, helping explain why they tend to be less aggressive. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2020 Category: Cancer & Oncology Source Type: news

Targeting a transporter to treat SHH medulloblastoma
(St. Jude Children's Research Hospital) Scientists at St. Jude Children's Research Hospital have identified a novel target for a type of pediatric brain tumor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 31, 2020 Category: International Medicine & Public Health Source Type: news

Good news for NF patients with low grade glioma (LGG)
(Children's Tumor Foundation) A paper published in the academic journal Neuro-Oncology by NF experts has demonstrated an increased understanding of low grade gliomas (LGG) occurring in children and adults with NF1. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2020 Category: Biology Source Type: news

What Types of Memory Impairments are There in Children?
Discussion Memory is an important part of what distinguishes higher order species from others. Memory also is part of one’s self-identity. Difficulties in short-term memory can make common, everyday tasks difficult for the person experiencing the problem particularly if it recently occurred and the person’s long-term memory is intact. Difficulties with long-term memory can also have problems when language, events or even one’s own identity are affected. For some people the memory loss is temporary but for others, memory impairments are permanent and must be accepted and accommodated as part of the overall...
Source: PediatricEducation.org - March 30, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Machine learning helps doctors diagnose severity of brain tumors
A machine learning model developed by Yale ’s Dr. Murat Günel makes predictions to help doctors diagnose the stage of brain cancers faster and more accurately. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 25, 2020 Category: Universities & Medical Training Source Type: news

CAR T Cell Adds Scorpion Venom to Tackle Tumor Heterogeneity
A newly engineered CAR T cell that incorporates a peptide isolated from the venom of the deathstalker scorpion has broad brain tumor–binding capabilities that will be investigated in an... (Source: The Scientist)
Source: The Scientist - March 24, 2020 Category: Science Tags: News & Opinion Source Type: news

10 Years Later, Obamacare ’s Complicated Legacy Still Shapes the Nation
Maurine Stuart credits the Affordable Care Act (ACA) for saving her family. In 2014, Stuart was diagnosed with HELLP syndrome, a rare disease that causes heart, liver and lymphatic problems. As a result, she was unable to continue working full time—which meant losing her employer-sponsored health insurance. But thankfully, she says, that same year, her home state of West Virginia opted in to the 2010 Affordable Care Act’s Medicaid-coverage expansion, and she qualified. Over the next few years, as bad news kept rolling in, ACA protections continued to keep Stuart’s family afloat. When Stuart was diagnosed ...
Source: TIME: Health - March 19, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Source Type: news

Zika combats advanced-stage central nervous system tumors in dogs
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) The viral therapy was tested in three elderly animals with spontaneous brain tumors by a group affiliated with the FAPESP-funded Human Genome and Stem Cell Research Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2020 Category: Cancer & Oncology Source Type: news

NorthShore neurosurgeon first in Illinois to offer new targeted therapy for brain tumors
(NorthShore University HealthSystem) NorthShore University HealthSystem is the first in the state of Illinois to offer this new, advanced neurosurgery technique to offer more tumor free living with fewer side effects for brain tumor patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 10, 2020 Category: Cancer & Oncology Source Type: news

NeuroPace Removes Barrier for Epilepsy Treatment Through FDA Nod
NeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based company’s RNS System treats patients living with seizures that do not respond to medication and first landed a PMA in November of 2013. In a release, the company said individuals with focal onset seizures that also have brain anomalies that require monitoring, such as tuberous sclerosis, brain tumors or multiple sclerosis, as well as those with non-brain MRI requirements, can now be offered the RNS System as a treatment option. The company added this will also a...
Source: MDDI - March 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Regulatory and Compliance Source Type: news

Brain Cancer Research Could Help Dogs AND Kids
Striving to cure pet dogs with brain tumors and learning which therapies work best -- and why -- could inform cancer treatments for children with these tumors, the researchers concluded. (Source: WebMD Health)
Source: WebMD Health - March 6, 2020 Category: Consumer Health News Source Type: news

Brain Cancer Research Could Help Dogs -- and the Humans Who Love Them
FRIDAY, March 6, 2020 -- Few heartbreaks are as devastating as when a beloved family dog falls ill with cancer. But a new research paper could spur development of more and better treatments for a canine companion who has a brain tumor -- because... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 6, 2020 Category: General Medicine Source Type: news